StockDrifts LogoStockDrifts

J2K Bio 420570

Company
제이투케이바이오J2K Bio
Insiders
1
Buys
2
Total Value
₩36M ($25K)
Avg Return
+31.69%
Last Filing
2026-05-07

J2K Bio (420570) has 2 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩36M ($25K) in reported transaction value. The earliest filing StockDrifts holds for J2K Bio is dated 2024-03-25; the most recent is 2026-05-07. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +31.69%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-05-07BUYMarket Buy
김석종
Seokjong Kim
Managing Director2.3K₩7,870+33.4%₩18M ($13K)
2026-05-06BUYMarket Buy
김석종
Seokjong Kim
Managing Director2.1K₩8,080+29.9%₩17M ($12K)
2024-03-25BUY무상신주취득
배준태
Juntae Bae
moving139.5K₩26,000-67.5%₩3.6B ($2.5M)
2024-03-25BUY무상신주취득
이재섭
Jaeseop Lee
CEO1.4M₩26,000-67.5%₩37.5B ($26.0M)
2024-03-25BUY무상신주취득
김대찬
Daechan Kim
Managing Director930.0K₩26,000-67.5%₩24.2B ($16.8M)
2024-03-25BUY무상신주취득
김석종
Seokjong Kim
Managing Director930.0K₩26,000-67.5%₩24.2B ($16.8M)

Frequently asked questions

Who has been buying J2K Bio stock?
1 distinct insiders have filed 2 disclosed insider purchases in J2K Bio (420570), most recently on 2026-05-07. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does J2K Bio have?
J2K Bio has 2 buy-side and 0 sell-side disclosures on record, covering ₩36M ($25K) in total reported value, spanning 2024-03-25 to 2026-05-07.
Where does StockDrifts get J2K Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for J2K Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.